Moderna
Cambridge, US · Founded 2016 · 6,242 employees on LinkedIn · 7 known investors
Moderna develops mRNA-based medicines for infectious and serious diseases using its proprietary mRNA platform and design technology.
Founders & leadership
Moderna was founded in 2016 by Robert Langer.
RL
Robert LangerFounder
LK
Lorence KimExecutive
JR
James R. KasingerExecutive
SH
Stephen HogeExecutive
TM
Theo Melas-KyriaziNamed on SEC filing
RC
Robert CarpenterNamed on SEC filing
Board
SB
Stephane BancelBoard directorPartner at Flagship Pioneering
JM
John MendleinBoard director
NA
PH
Peter HuttBoard director
EN
Elizabeth NabelBoard director
HT
Henri TermeerBoard director
Investors · 7
Reported raises · per SEC filings
Form D private placements$1B disclosed across 3 rounds · 2013–2016
▶$451.4MraisedAug 2016 · 72 investors · BiotechnologyRule 506(b)
▶$451.4MraisedAug 2016 · 72 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lorence KimExecutive Officer
- Stephane BancelExecutive Officer, Director
- Robert LangerDirector
- Peter HuttDirector
- John MendleinDirector
- James R. KasingerExecutive Officer
- Elizabeth NabelDirector
- Stephen HogeExecutive Officer
- Henri TermeerDirector
- Noubar AfeyanDirector
- Lee BabissDirector
- Offering amount
- $600M
- Amount sold
- $451.4M
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$446.1MraisedJan 2015 · 43 investors · PharmaceuticalsRule 506(b)
▶$446.1MraisedJan 2015 · 43 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Stephane BancelExecutive Officer, Director
- Lorence KimExecutive Officer
- James KasingerExecutive Officer
- Noubar AfeyanDirector
- Lee BabissDirector
- Robert CarpenterDirector
- Theo Melas-KyriaziDirector
- Robert LangerDirector
- Peter HuttDirector
- John MendleinDirector
- Henri TermeerDirector
- Offering amount
- $502.2M
- Amount sold
- $446.1M
- First sale
- Dec 2014
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
▶$135MraisedJan 2014 · 40 investors · PharmaceuticalsRule 506(b)
▶$135MraisedJan 2014 · 40 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Henri TermeerDirector
- Lee BabissDirector
- Theo Melas-KyriaziDirector
- Robert CarpenterDirector
- John MendleinDirector
- Robert LangerDirector
- Noubar AfeyanDirector
- Stephane BancelExecutive Officer, Director
- Peter HuttDirector
- Offering amount
- $135M
- Amount sold
- $135M
- First sale
- Nov 2013
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Moderna for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
OCC urges Congress to boost federal pipeline safety grant funding in Oklahomajournalrecord.com · Jul 2026
Lyora Therapeutics Launches With Seed Funding to Propel Its Biologically Validated Pipeline of Genetic Medicines to Treat Inherited Retinal Diseases | The Manila Timesmanilatimes.net · Jul 2026
Erasca Raises $550M for RAS-Targeting Cancer Pipelineallsci.com · Jul 2026Frequently asked questions
- What does Moderna do?
- Moderna develops mRNA-based medicines for infectious and serious diseases using its proprietary mRNA platform and design technology.
- Who founded Moderna?
- Moderna was founded by Robert Langer in 2016.
- Who are Moderna's investors?
- Moderna's investors include Aglae Ventures, Blackstone Life Sciences, Flagship Pioneering, FPV, Khosla Ventures, Premji Invest, RA Capital.
- How much funding has Moderna raised?
- Moderna has disclosed $1B raised across 3 rounds.
- Where is Moderna headquartered?
- Moderna is headquartered in Cambridge, US.